Metformin Hydrochloride Phoenix 500 mg prolonged - release tablets Bułgaria - bułgarski - Изпълнителна агенция по лекарствата

metformin hydrochloride phoenix 500 mg prolonged - release tablets

500 mg prolonged - release tablets

Metformin Hydrochloride Phoenix 750 mg prolonged - release tablets Bułgaria - bułgarski - Изпълнителна агенция по лекарствата

metformin hydrochloride phoenix 750 mg prolonged - release tablets

750 mg prolonged - release tablets

Natrium Chlorid Alkaloid 9 mg/ml solution for infusion Bułgaria - bułgarski - Изпълнителна агенция по лекарствата

natrium chlorid alkaloid 9 mg/ml solution for infusion

9 mg/ml solution for infusion

Potassium Chloride + Glucose Kabi 1,5 mg/ml + 50 mg/ml solution for infusion Bułgaria - bułgarski - Изпълнителна агенция по лекарствата

potassium chloride + glucose kabi 1,5 mg/ml + 50 mg/ml solution for infusion

1,5 mg/ml + 50 mg/ml solution for infusion

Potassium Chloride + Glucose Kabi 3 mg/ml + 50 mg/ml solution for infusion Bułgaria - bułgarski - Изпълнителна агенция по лекарствата

potassium chloride + glucose kabi 3 mg/ml + 50 mg/ml solution for infusion

3 mg/ml + 50 mg/ml solution for infusion

AMPROLIUM 20 % oral 200 mg/ml Bułgaria - bułgarski - БАБХ (Българска агенция по безопасност на храните)

amprolium 20 % oral 200 mg/ml

kepro b.v. - Ампролиум хидрохлорид - разтвор за прилагане във вода за пиене - 200 mg/ml - пилета, пуйки

Sevelamer Hydrochloride Waymade  400 mg film - coated tablets Bułgaria - bułgarski - Изпълнителна агенция по лекарствата

sevelamer hydrochloride waymade  400 mg film - coated tablets

400 mg film - coated tablets

Sevelamer Hydrochloride Waymade  800 mg film - coated tablets Bułgaria - bułgarski - Изпълнителна агенция по лекарствата

sevelamer hydrochloride waymade  800 mg film - coated tablets

800 mg film - coated tablets

КАЛЦИН, инжекционен разтвор Bułgaria - bułgarski - БАБХ (Българска агенция по безопасност на храните)

КАЛЦИН, инжекционен разтвор

Биофарм Инженеринг АД - calcium gluconate, calcium glycerophosphate, magnesium chloride hexahydrate, caffeine - инжекционен разтвор - 16.00 g/100 ml, 6.60 g/100 ml, 6.40 g/100 ml, 2.50 g/100 ml - говеда, кози, коне, кучета, овце, свине

Lenalidomide Krka d.d. Novo mesto (previously Lenalidomide Krka) Unia Europejska - bułgarski - EMA (European Medicines Agency)

lenalidomide krka d.d. novo mesto (previously lenalidomide krka)

krka, d.d., novo mesto  - lenalidomide hydrochloride monohydrate - multiple myeloma; lymphoma, follicular - Имуносупресори - multiple myelomalenalidomide krka d. novo mesto as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. novo mesto as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) е показан за лечение на възрастни пациенти с по-рано нелекувана множествена миеломой, на които не се разчита за трансплантация. lenalidomide krka d. novo mesto in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide krka d. novo mesto in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a). multiple myelomalenalidomide krka d. novo mesto as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. novo mesto as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) е показан за лечение на възрастни пациенти с по-рано нелекувана множествена миеломой, на които не се разчита за трансплантация. lenalidomide krka d. novo mesto in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide krka d. novo mesto in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).